• Enhanced Stability & Scalable Manufacturing – Lipopeptides form highly stable particles that protect RNA during processing and storage, enabling reproducible largescale production and simplified cold-chain logistics
• Improved Safety Profile – Ionizable-lipid-free design reduces inflammatory and toxic responses, supporting repeated dosing and broad therapeutic use
• Precise Extra-Hepatic Delivery – Cell-penetrating and targeting functions allow efficient uptake beyond the liver, expanding RNA therapy to cardiovascular, pulmonary, and other hard-to-reach tissues. Case study of gene therapy for use in vascular disease application enabled by GENESYS™ targeted delivery platform

NEW COMPANY